These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 34755305)

  • 21. BCG revaccination of health workers in Brazil to improve innate immune responses against COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Junqueira-Kipnis AP; Dos Anjos LRB; Barbosa LCS; da Costa AC; Borges KCM; Cardoso ADRO; Ribeiro KM; Rosa SBA; Souza CC; das Neves RC; Saraiva G; da Silva SM; Silveira EA; Rabahi MF; Conte MB; Kipnis A
    Trials; 2020 Oct; 21(1):881. PubMed ID: 33106170
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Engineering a dual vaccine against COVID-19 and tuberculosis.
    Guthrie CM; Tan X; Meeker AC; Self AE; Liu L; Cheng Y
    Front Cell Infect Microbiol; 2023; 13():1273019. PubMed ID: 37965265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is the BCG vaccine a useful tool against COVID-19?
    Zhelezova G; Mateeva V; Mateev G
    Clin Dermatol; 2021; 39(1):98-103. PubMed ID: 33972060
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The BCG Vaccine for COVID-19: First Verdict and Future Directions.
    Gonzalez-Perez M; Sanchez-Tarjuelo R; Shor B; Nistal-Villan E; Ochando J
    Front Immunol; 2021; 12():632478. PubMed ID: 33763077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Convergence between global BCG vaccination and COVID-19 pandemic.
    Islam MZ; Zahan MK; Al-Bari MAA
    J Med Virol; 2021 Mar; 93(3):1496-1505. PubMed ID: 32827313
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Accelerated induction of mycobacterial antigen-specific CD8+ T cells in the Mycobacterium tuberculosis-infected lung by subcutaneous vaccination with Mycobacterium bovis bacille Calmette-Guérin.
    Begum D; Umemura M; Yahagi A; Okamoto Y; Hamada S; Oshiro K; Matsuzaki G
    Immunology; 2009 Dec; 128(4):556-63. PubMed ID: 19930045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of BCG vaccination on infection and antibody levels against SARS-CoV-2-The results of ProBCG: a multicenter randomized clinical trial in Brazil.
    Santos AP; Werneck GL; Dalvi APR; Dos Santos CC; Tierno PFGMM; Condelo HS; Macedo B; de Medeiros Leung JA; de Souza Nogueira J; Malvão L; Galliez R; Aguiar R; Stefan R; Knackfuss SM; da Silva EC; Castineiras TMPP; de Andrade Medronho R; E Silva JRL; Alves RLR; de Moraes Sobrino Porto LC; Rodrigues LS; Kritski AL; de Queiroz Mello FC
    Int J Infect Dis; 2023 May; 130():8-16. PubMed ID: 36841502
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BCG vaccination provides protection against IAV but not SARS-CoV-2.
    Kaufmann E; Khan N; Tran KA; Ulndreaj A; Pernet E; Fontes G; Lupien A; Desmeules P; McIntosh F; Abow A; Moorlag SJCFM; Debisarun P; Mossman K; Banerjee A; Karo-Atar D; Sadeghi M; Mubareka S; Vinh DC; King IL; Robbins CS; Behr MA; Netea MG; Joubert P; Divangahi M
    Cell Rep; 2022 Mar; 38(10):110502. PubMed ID: 35235831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bacillus Calmette-Guérin-induced trained immunity protects against SARS-CoV-2 challenge in K18-hACE2 mice.
    Zhang BZ; Shuai H; Gong HR; Hu JC; Yan B; Yuen TT; Hu YF; Yoon C; Wang XL; Hou Y; Lin X; Huang X; Li R; Au-Yeung YM; Li W; Hu B; Chai Y; Yue M; Cai JP; Ling GS; Hung IF; Yuen KY; Chan JF; Huang JD; Chu H
    JCI Insight; 2022 Jun; 7(11):. PubMed ID: 35446790
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BCG-Induced Cross-Protection and Development of Trained Immunity: Implication for Vaccine Design.
    Covián C; Fernández-Fierro A; Retamal-Díaz A; Díaz FE; Vasquez AE; Lay MK; Riedel CA; González PA; Bueno SM; Kalergis AM
    Front Immunol; 2019; 10():2806. PubMed ID: 31849980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An update on COVID-19: SARS-CoV-2 life cycle, immunopathology, and BCG vaccination.
    Khade SM; Yabaji SM; Srivastava J
    Prep Biochem Biotechnol; 2021; 51(7):650-658. PubMed ID: 33226885
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of antigen-specific CD4+ HLA-DR-restricted cytotoxic T lymphocytes as well as nonspecific nonrestricted killer cells by the recombinant mycobacterial 65-kDa heat-shock protein.
    Ab BK; Kiessling R; Van Embden JD; Thole JE; Kumararatne DS; Pisa P; Wondimu A; Ottenhoff TH
    Eur J Immunol; 1990 Feb; 20(2):369-77. PubMed ID: 1690136
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Duration of immunity against Mycobacterium bovis following neonatal vaccination with bacillus Calmette-Guérin Danish: significant protection against infection at 12, but not 24, months.
    Thom ML; McAulay M; Vordermeier HM; Clifford D; Hewinson RG; Villarreal-Ramos B; Hope JC
    Clin Vaccine Immunol; 2012 Aug; 19(8):1254-60. PubMed ID: 22718125
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recombinant Bacillus Calmette-Guérin Expressing SARS-CoV-2 Chimeric Protein Protects K18-hACE2 Mice against Viral Challenge.
    Mambelli F; Marinho FV; Andrade JM; de Araujo ACVSC; Abuna RPF; Fabri VMR; Santos BPO; da Silva JS; de Magalhães MTQ; Homan EJ; Leite LCC; Dias GBM; Heck N; Mendes DAGB; Mansur DS; Báfica A; Oliveira SC
    J Immunol; 2023 Jun; 210(12):1925-1937. PubMed ID: 37098890
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BCG and SARS-CoV-2-What Have We Learned?
    Kulesza J; Kulesza E; Koziński P; Karpik W; Broncel M; Fol M
    Vaccines (Basel); 2022 Sep; 10(10):. PubMed ID: 36298506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Repurposing of the childhood vaccines: could we train the immune system against the SARS-CoV-2.
    Sharma D
    Expert Rev Vaccines; 2021 Sep; 20(9):1051-1057. PubMed ID: 34313516
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bacillus calmette-guerin as a quick and temporary solution to coronavirus disease-2019.
    Kumari P; Gupta UD; Bhagyawant SS
    Int J Mycobacteriol; 2021; 10(2):105-110. PubMed ID: 34558459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BCG-induced protection: effects on innate immune memory.
    Netea MG; van Crevel R
    Semin Immunol; 2014 Dec; 26(6):512-7. PubMed ID: 25444548
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of circadian rhythm on Bacillus Calmette-Guérin vaccination effects on SARS-CoV-2 infections.
    Föhse K; Taks EJM; Moorlag SJCFM; Bonten MJM; van Crevel R; Ten Oever J; van Werkhoven CH; Netea MG; van de Maat JS; Hoogerwerf JJ
    Front Immunol; 2023; 14():980711. PubMed ID: 36875134
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New disease old vaccine: Is recombinant BCG vaccine an answer for COVID-19?
    Gupta PK
    Cell Immunol; 2020 Oct; 356():104187. PubMed ID: 32745670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.